The government intends to award a sole source contract to BIORAD Laboratories for the acquisition of BIORAD Antibodies under simplified acquisition procedures. This is a notice of intent, not a request for proposals, and no solicitation document exists. Interested parties may submit capability documentation, including pricing and technical data, to demonstrate they can provide a comparable source. Expressions of interest must be received by 1:00 AM ET on 1-AUG-2026. No budget amount or performance location is specified in the notice.